New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases

Thrombosis and Haemostasis

Volumn 104, Issue 3, 2010, Pages 485-497

  Oliveira, Ana K ^a   Paes Leme, Adriana F ^a   Asega, Amanda F ^a   Camargo, Antonio C M ^a   Fox, Jay W ^b   Serrano, Solange M T ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Extracellular matrix; Haemorrhage; Metalloproteinase; Proteolysis; Snake venom

Indexed keywords

BOTHROPASIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 6; CYSTEINE; DISINTEGRIN; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN; MATRIGEL; METALLOPROTEINASE; SNAKE VENOM; UNCLASSIFIED DRUG; VITRONECTIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BLEEDING; CAPILLARY; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME STABILITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; EXTRAVASATION; GLYCOSYLATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; SKIN BLEEDING; SOLID;

ANIMALS; BLOOD PROTEINS; BOTHROPS; CROTALID VENOMS; EXTRACELLULAR MATRIX PROTEINS; GLYCOSYLATION; HEMORRHAGE; HUMANS; METALLOENDOPEPTIDASES; METALLOPROTEASES; MICE; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SKIN DISEASES; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 77956624674     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-12-0855     Document Type: Article

References (53)

1. Takahashi T, Ohsaka A. Purification and characterization of a proteinase in the venom of Trimeresurus flavoviridis. Complete separation of the enzyme from hemorrhagic activity. Biochim Biophys Acta 1970; 198: 293-307.
2. Shannon JD, Baramova EN, Bjarnason JB, et al. Amino acid sequence of a Crotalus atrox venom metalloproteinase which cleaves type IV collagen and gelatin. J Biol Chem 1989; 264: 11575-11583.
3. Rucavado A, Lomonte B, Ovadia M, et al. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom. Exp Mol Pathol 1995; 63: 186-199.
4. Gutiérrez JM, Rucavado A, Escalante T, et al. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005; 45: 997-1011.
5. Rucavado A, Soto M, Escalante T, et al. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. Thromb Haemost 2005; 94: 123-131.
6. Wu WB, Peng HC, Huang TF. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox. Thromb Haemost 2001; 86: 1501-1511.
7. Wang WJ, Huang TF. Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom. Thromb Haemost 2002; 87: 641-650.
8. Fox JW, Serrano SM. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005; 45: 969-985.
9. Laing GD, Moura-da-Silva AM, Jararhagin and its multiple effects on hemostasis. Toxicon 2005; 45: 987-996.
10. Kamiguti AS. Platelets as targets of snake venom metalloproteinases. Toxicon 2005; 45: 1041-1049. (Pubitemid 40732579)
11. Bjarnason JB, Fox JW. Snake venom metalloendopeptidases: reprolysins. Methods Enzymol 1995; 248: 345-368.
12. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol 1998; 10: 654-659.
13. Tang BL, Hong W. ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett 1999; 445: 223-225.
14. Fox JW, Serrano SM. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J 2008; 275: 3016-3030.
15. Kamiguti AS, Slupsky JR, Zuzel M, et al. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca. Thromb Haemost 1994; 72: 244-249.
16. Hamako J, Matsui T, Nishida S, et al. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom. Thromb Haemost 1998; 80: 499-505.
17. Serrano SM, Wang D, Shannon JD, et al. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. FEBS J 2007; 274: 3611-3621.
18. Baldo C, Tanjoni I, León IR, et al. BnP1, a novel P-I metalloproteinase from Bothrops neuwiedi venom: biological effects benchmarking relatively to jararhagin, a P-III SVMP. Toxicon 2008; 51: 54-65.
19. White JM. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 2003; 15: 598-606.
20. Porter S, Clark IM, Kevorkian L, et al. The ADAMTS metalloproteinases. Biochem J 2005; 386: 15-27.
21. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003; 17: 7-30.
22. Luken BM, Turenhout EA, Hulstein JJ, et al. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 2005; 93: 267-274.
23. Gerhardt S, Hassall G, Hawtin P, et al. Crystal structures of human ADAMTS1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J Mol Biol 2007; 373: 891-902. (Pubitemid 47505246)
24. Groot R, Bardhan A, Ramroop N, et al. Essential role of the disintegrin-like domain in ADAMTS13 function. Blood 2009; 113: 5609-5616.
25. Serrano SM, Jia LG, Wang D, et al. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor. Biochem J 2005; 391: 69-76.
26. Serrano SM, Kim J, Wang D, et al. The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting. J Biol Chem 2006; 281: 39746-39756.
27. Menezes MC, Paes Leme AF, Melo RL, et al. Activation of leukocyte rolling by the cysteine-rich domain and the hyper-variable region of HF3, a snake venom hemorrhagic metalloproteinase. FEBS Lett 2008; 582: 3915-3921.
28. Assakura MT, Reichl AP, Mandelbaum FR. Comparison of immunological, biochemical and biophysical properties of three hemorrhagic factors isolated from the venom of Bothrops jararaca (jararaca). Toxicon 1986; 24: 943-946.
29. Silva CA, Zuliani JP, Assakura MT, et al. Activation of alpha(M)beta(2)-mediated phagocytosis by HF3, a P-III class metalloproteinase isolated from the venom of Bothrops jararaca. Biochem. Biophys Res Commun 2004; 322: 950-956.
30. Mandelbaum FR, Reichel AP, Assakura MT. Isolation and characterization of a proteolytic enzyme from the venom of the snake Bothrops jararaca (Jararaca). Toxicon 1982; 20: 955-972.
31. Assakura MT, Silva CA, Mentele R, et al. Molecular cloning and expression of structural domains of bothropasin, a P-III metalloproteinase from the venom of Bothrops jararaca. Toxicon 2003; 41: 217-227.
32. Oliveira AK, Paes Leme AF, Assakura MT, et al. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel P-I metalloproteinase from Bothrops jararaca venom. Toxicon 2009; 53: 797-801.
33. Usami Y, Fujimura Y, Miura S, et al. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem Biophys Res Commun 1994; 201: 331-339.
34. Moura-da-Silva AM, Della-Casa MS, David AS, et al. Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability. Arch Biochem Biophys 2003; 409: 395-401.
35. Ohsaka A. Handbook of Experimental Pharmacology. In: Snake Venoms. C.Y. Lee (Ed.), Springer-Verlag, Berlin 1979; 480-546.
36. Kamiguti AS, Hay CRM, Theakston RDG, et al. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996; 34: 627-642.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
38. Steel LF, Trotter MG, Nakajima PB, et al. Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics 2003; 2: 262-270.
39. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203.
40. Paes Leme AF, Prezoto BC, Yamashiro ET, et al. Bothrops protease A, a unique highly glycosylated serine proteinase, is a potent, specific fibrinogenolytic agent. J Thromb Haemost 2008; 6: 1363-1372.
41. Baramova EN, Shannon JD, Bjarnason JB, et al. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases. Arch Biochem Biophys 1989; 275: 63-71. (Pubitemid 19280687)
42. Escalante T, Shannon J, Moura-da-Silva AM, et al. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study. Arch Biochem Biophys 2006; 455: 144-153.
43. Makogonenko E, Tsurupa G, Ingham K, et al. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry 2002; 41: 7907-7913. (Pubitemid 34655155)
44. Preissner KT, Holzhüter S, Justus C, et al. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 1989; 74: 1989-1996.
45. Corbett SA, Lee L, Wilson CL, et al. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem 1997; 272: 24999-25005.
46. Podor TJ, Campbell S, Chindemi P, et al. Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen. J Biol Chem 2002; 277: 7520-7528. (Pubitemid 34953150)
47. Tseng YL, Wu WB, Hsu CC, et al. Inhibitory effects of human alpha2-macroglobulin and mouse serum on the PSGL-1 and glycoprotein Ib proteolysis by a snake venom metalloproteinase, triflamp. Toxicon 2004; 43: 769-777.
48. Escalante T, Rucavado A, Kamiguti AS, et al. Bothrops asper metalloproteinase BaP1 is inhibited by alpha(2)-macroglobulin and mouse serum and does not induce systemic hemorrhage or coagulopathy. Toxicon 2004; 43: 213-217.
49. Baramova EN, Shannon JD, Bjarnason JB, et al. Interaction of hemorrhagic metalloproteinases with human a2-macroglobulin. Biochemistry 1990; 29: 1069-1074.
50. Tanjoni I, Evangelista K, Della-Casa MS, et al. Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha(2)beta(1) integrin and collagen. Toxicon 2010; Epub ahead of print.
51. Moura-da-Silva AM, Ramos OH, Baldo C, et al. Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Biochimie 2008; 90: 484-492.
52. Gowda DC, Jackson CM, Kurzban GP, et al. Core sugar residues of the N-linked oligosaccharides of Russell's viper venom factor X-activator maintain functionally active polypeptide structure. Biochemistry 1996; 35: 5833-5837.
53. Chen HS, Chen JM, Lin CW, et al. New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom. FEBS J 2008; 275: 3944-3958.